Penserra Capital Management’s Celgene Corp CELG Stock Holding History

Penserra Capital Management’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-5,966	Closed	-$551K	–	1006
2019 Q2	$551K	Buy	+5,966	New	+$567K	0.04%	288
2018 Q4	–	Sell	-3,220	Closed	-$288K	–	842
2018 Q3	$288K	Buy	3,220 +455	+16%	+$40.2K	0.02%	384
2018 Q2	$219K	Buy	+2,765	New	+$230K	0.01%	305
2017 Q4	–	Sell	-5,637	Closed	-$821K	–	637
2017 Q3	$821K	Buy	5,637 +3,973	+239%	+$541K	0.2%	82
2017 Q2	$216K	Buy	+1,664	New	+$204K	0.08%	192
2017 Q1	–	Sell	-188	Closed	-$21K	–	964
2016 Q4	$21K	Buy	188 +38	+25%	+$4.23K	﹤0.01%	608
2016 Q3	$15K	Buy	150 +60	+67%	+$6.49K	﹤0.01%	735
2016 Q2	$9K	Buy	90 +30	+50%	+$3.1K	﹤0.01%	786
2016 Q1	$6	Buy	60 +8	+15%	+$824	﹤0.01%	819
2015 Q4	$6K	Buy	+52	New	+$6.02K	﹤0.01%	778

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Penserra Capital Management's CELG Position: Q3 2019 in Review

Penserra Capital Management sold out of Celgene Corp (CELG) in Q3 2019, closing a stake of 5,966 shares — an estimated $551K sold.

Penserra Capital Management first reported a position in CELG in Q4 2015 and held it in 10 quarters. The position peaked at $821K in Q3 2017. 1,245 funds tracked by Wall St. Rank hold CELG as of Q3 2019.

Penserra Capital Management reported no remaining Celgene Corp position as of Q3 2019 after selling out during the quarter.
Penserra Capital Management sold 5,966 Celgene Corp shares in Q3 2019, an estimated $551K.
Penserra Capital Management first reported a position in Celgene Corp in Q4 2015 and held it in 10 quarters.
Penserra Capital Management's Celgene Corp position peaked at $821K in Q3 2017.
1,245 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2019.

Based on Penserra Capital Management's 13F filing for Q3 2019, filed 15 Nov 2019.